Skip to content
THE RED ROBOT

THE RED ROBOT

  • All News
  • E-Commerce
  • Ethics & Law
  • Crypto
  • Ideas
    • Product Ideas
    • Investment Ideas
  • All News
  • E-Commerce
  • Ethics & Law
  • Crypto
  • Ideas
    • Product Ideas
    • Investment Ideas
  • All News
  • E-Commerce
  • Ethics & Law
  • Crypto
  • Ideas
    • Product Ideas
    • Investment Ideas
Copyright (c) redrobot.online -- News and ideas of the digital world
  • Home
  • GARDP

GARDP

1 post
Zoliflodacin Phase 3 trial reveals 96.4% cure rate for uncomplicated urogenital gonorrhea
Posted in Hot Topic Medtech

Zoliflodacin Phase 3 trial reveals 96.4% cure rate for uncomplicated urogenital gonorrhea

Estimated read time 5 min read
Posted 7 months ago

A study in The Lancet shows zoliflodacin, a single-dose oral antibiotic, achieves 96.4% microbiological cure rates, matching standard care. With…

Read More Tagged antibiotics, Antimicrobial Resistance, Clinical Trials, FDA, GARDP, gonorrhea, Public Health, zoliflodacin
Copyright (c) redrobot.online -- News and ideas of the digital world